Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

COMMENT

Met amplification and HSP90 inhibitors

Giuseppe Giaccone, Arun Rajan

Cell Cycle 2009 September 1, 8 (17): 2682

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Cancer cells harboring MET gene amplification activate alternative signaling pathways to escape MET inhibition but remain sensitive to Hsp90 inhibitors. Suiquan Wang, Itai Pashtan, Shinji Tsutsumi, Wanping Xu, Len Neckers Cell Cycle 2009 July 1, 8 (13): 2050-6

[Study on signal transduction pathway in differentiation and apoptosis of leukemia cells induced by heat shock protein inhibitor]. Wen-Juan Yu, Qing Rao, Min Wang, Zheng Tian, Zhi-Fang Xu, Jian-Xiang Wang Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi 2007, 28 (10): 677-80

BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90. Karen Lundgren, Hong Zhang, John Brekken, Nanni Huser, Rachel E Powell, Noel Timple, David J Busch, Laura Neely, John L Sensintaffar, Yong-ching Yang, Andres McKenzie, Jessica Friedman, Robert Scannevin, Adeela Kamal, Kevin Hong, Srinivas R Kasibhatla, Marcus F Boehm, Francis J Burrows Molecular Cancer Therapeutics 2009, 8 (4): 921-9

Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors. Ming-Qiang Zhang, Sabine Gaisser, Mohammad Nur-E-Alam, Lesley S Sheehan, William A Vousden, Nikolaos Gaitatzis, Gerrard Peck, Nigel J Coates, Steven J Moss, Markus Radzom, Teresa A Foster, Rose M Sheridan, Matthew A Gregory, S Mark Roe, Chrisostomos Prodromou, Laurence Pearl, Susan M Boyd, Barrie Wilkinson, Christine J Martin Journal of Medicinal Chemistry 2008 September 25, 51 (18): 5494-7

Heat shock protein 90: inhibitors in clinical trials. Marco A Biamonte, Ryan Van de Water, Joseph W Arndt, Robert H Scannevin, Daniel Perret, Wen-Cherng Lee Journal of Medicinal Chemistry 2010 January 14, 53 (1): 3-17

HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cells. Rekha Rao, Warren Fiskus, Yonghua Yang, Pearl Lee, Rajeshree Joshi, Pravina Fernandez, Aditya Mandawat, Peter Atadja, James E Bradner, Kapil Bhalla Blood 2008 September 1, 112 (5): 1886-93

Hsp90 inhibitors, GA and 17AAG, lead to ER stress-induced apoptosis in rat histiocytoma. Aftab Taiyab, Amere S Sreedhar, Ch Mohan Rao Biochemical Pharmacology 2009 July 15, 78 (2): 142-52

Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells. Ryosuke Kurashina, Junko H Ohyashiki, Chiaki Kobayashi, Ryoko Hamamura, Yu Zhang, Toshihiko Hirano, Kazuma Ohyashiki Cancer Letters 2009 October 18, 284 (1): 62-70

HSP90 inhibitor 17AAG causes apoptosis in ATRA-resistant acute promyelocytic leukemia cells. Paul N Meyer, Shantanu Roychowdhury, Ameet R Kini, Serhan Alkan Leukemia Research 2008, 32 (1): 143-9

Re: Jin E and Santo M "Neurite outgrowth of NG08-15 cells induced by heat shock protein 90 inhibitors". Bruce G Gold Cell Biochemistry and Function 2008, 26 (6): 740

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Met amplification and HSP90 inhibitors

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips